ReviewESMO gastrointestinal oncology2024

Clinical impact of circulating tumor DNA to track minimal residual disease in colorectal cancer patients. Hopes and limitations.

C Soueidy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.